{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T13:24:26Z","timestamp":1764681866024,"version":"3.46.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis"],"published-print":{"date-parts":[[2000,3]]},"DOI":"10.1016\/s0027-5107(99)00232-8","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T10:39:58Z","timestamp":1027593598000},"page":"139-151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"title":["Central role of PPAR\u03b1 in the mechanism of action of hepatocarcinogenic peroxisome proliferators"],"prefix":"10.1016","volume":"448","author":[{"given":"J.Christopher","family":"Corton","sequence":"first","affiliation":[]},{"given":"Paula J","family":"Lapinskas","sequence":"additional","affiliation":[]},{"given":"Frank J","family":"Gonzalez","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0027-5107(99)00232-8_BIB1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.pa.29.040189.001045","article-title":"Biochemical mechanisms of induction of hepatic peroxisome proliferation","volume":"29","author":"Lock","year":"1989","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/283397a0","article-title":"Hypolipidemic hepatic peroxisome proliferators form a novel class of chemical carcinogens","volume":"283","author":"Reddy","year":"1980","journal-title":"Nature"},{"key":"10.1016\/S0027-5107(99)00232-8_BIB3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0300-483X(89)90207-2","article-title":"Failure of the peroxisome proliferator WY-14,643 to initiate growth-selectable foci in rat liver","volume":"56","author":"Cattley","year":"1989","journal-title":"Toxicology"},{"key":"10.1016\/S0027-5107(99)00232-8_BIB4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0304-3835(89)90003-7","article-title":"Lack of initiating activity of the peroxisome proliferator ciprofibrate in two-stage hepatocarcinogenesis","volume":"44","author":"Glauert","year":"1989","journal-title":"Cancer Lett."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB5","series-title":"Monograph of Peroxisome Proliferation","first-page":"653","article-title":"Peroxisome proliferators as initiators and promoters of rodent hepatocarcinogenesis","author":"Popp","year":"1992"},{"key":"10.1016\/S0027-5107(99)00232-8_BIB6","first-page":"49","article-title":"A decision tree approach for carcinogen risk assessment","volume":"391","author":"Butterworth","year":"1995","journal-title":"Prog. Clin. Biol."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB7","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/0165-6147(86)90416-5","article-title":"Peroxisome proliferators and cancer: mechanisms and implications","volume":"7","author":"Reddy","year":"1986","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB8","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/347645a0","article-title":"Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators","volume":"347","author":"Issemann","year":"1990","journal-title":"Nature"},{"key":"10.1016\/S0027-5107(99)00232-8_BIB9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/384039a0","article-title":"The PPAR\u03b1-leukotriene B4 pathway to inflammation control","volume":"384","author":"Devchand","year":"1996","journal-title":"Nature"},{"key":"10.1016\/S0027-5107(99)00232-8_BIB10","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/31701","article-title":"Activation of human aortic smooth-muscle cells is inhibited by PPAR\u03b1 but not PPAR\u03b3 activators","volume":"393","author":"Staels","year":"1998","journal-title":"Nature"},{"key":"10.1016\/S0027-5107(99)00232-8_BIB11","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1101\/gad.13.12.1561","article-title":"Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPAR\u03b4","volume":"13","author":"Lim","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB12","doi-asserted-by":"crossref","first-page":"7921","DOI":"10.1073\/pnas.92.17.7921","article-title":"Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR) gamma gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms","volume":"92","author":"Zhu","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB13","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0092-8674(00)81359-8","article-title":"Adipogenesis and obesity: rounding out the big picture","volume":"87","author":"Spiegelman","year":"1996","journal-title":"Cell"},{"key":"10.1016\/S0027-5107(99)00232-8_BIB14","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1146\/annurev.bi.64.070195.002021","article-title":"Transcriptional regulation of gene expression during adipocyte differentiation","volume":"64","author":"MacDougald","year":"1995","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB15","doi-asserted-by":"crossref","first-page":"9116","DOI":"10.1074\/jbc.274.13.9116","article-title":"Peroxisome proliferator-activated receptor \u03b3 ligands are potent inhibitors of angiogenesis in vitro and in vivo","volume":"274","author":"Xin","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB16","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0959-437X(98)80014-2","article-title":"The nuclear receptor PPAR\u03b3 \u2014 bigger than fat","volume":"8","author":"Kliewer","year":"1998","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB17","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0092-8674(95)90199-X","article-title":"The nuclear receptor superfamily: the second decade","volume":"83","author":"Mangelsdorf","year":"1995","journal-title":"Cell"},{"key":"10.1016\/S0027-5107(99)00232-8_BIB18","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.1073\/pnas.94.9.4312","article-title":"Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors \u03b1 and \u03b4","volume":"94","author":"Forman","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB19","doi-asserted-by":"crossref","first-page":"7355","DOI":"10.1073\/pnas.91.15.7355","article-title":"Differential expression and activation of a family of murine peroxisome proliferator-activated receptors","volume":"91","author":"Kliewer","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB20","doi-asserted-by":"crossref","first-page":"12953","DOI":"10.1074\/jbc.270.22.12953","article-title":"An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3)","volume":"270","author":"Lehmann","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB21","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1074\/jbc.272.3.2013","article-title":"Ligand-induced peroxisome proliferator-activated receptor \u03b1 conformational change","volume":"272","author":"Dowell","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB22","doi-asserted-by":"crossref","first-page":"5530","DOI":"10.1016\/S0021-9258(18)53353-6","article-title":"Enantioselective activation of the peroxisome proliferator-activated receptor","volume":"268","author":"Boie","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB23","unstructured":"P.J. Lapinskas, S. Brown, R.C. Cattley, Role of peroxisome proliferator-activated receptor alpha in mediating phthalate-induced liver toxicity (submitted for publication)."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB24","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0092-8674(95)90194-9","article-title":"A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor \u03b3 and promotes adipocyte differentiation","volume":"83","author":"Kliewer","year":"1995","journal-title":"Cell"},{"key":"10.1016\/S0027-5107(99)00232-8_BIB25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1432-1033.1996.0001u.x","article-title":"A human peroxisome-proliferator-activated receptor-\u03b3 is activated by inducers of adipogenesis, including thiazolidinedione drugs","volume":"239","author":"Lambe","year":"1996","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB26","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1074\/jbc.272.6.3406","article-title":"Peroxisome proliferator-activated receptors \u03b1 and \u03b3 are activated by indomethacin and other non-steroidal anti-inflammatory drugs","volume":"272","author":"Lehmann","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB27","doi-asserted-by":"crossref","first-page":"6102","DOI":"10.1073\/pnas.96.11.6102","article-title":"A peroxisome proliferator-activated receptor \u03b3 ligand inhibits adipocyte differentiation","volume":"96","author":"Oberfield","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB28","series-title":"Molecular Biology of the Toxic Response","first-page":"219","article-title":"Molecular mechanisms of hepatocarcinogenic peroxisome proliferators","author":"Lapinskas","year":"1998"},{"key":"10.1016\/S0027-5107(99)00232-8_BIB29","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1073\/pnas.89.10.4653","article-title":"Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor","volume":"89","author":"Gottlicher","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB30","doi-asserted-by":"crossref","first-page":"23975","DOI":"10.1074\/jbc.270.41.23975","article-title":"Differential activation of peroxisome proliferator-activated receptors by eicosanoids","volume":"270","author":"Yu","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0960-0760(93)90058-5","article-title":"Xenopus peroxisome proliferator activated receptors: genomic organization, response element recognition, heterodimer formation with retinoid X receptor and activation by fatty acids","volume":"47","author":"Krey","year":"1993","journal-title":"J. Steroid Biochem."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB32","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.1073\/pnas.94.9.4318","article-title":"Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors \u03b1 and \u03b3","volume":"94","author":"Kliewer","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB33","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0041-008X(89)90056-2","article-title":"Differential induction and regulation of peroxisomal enzymes: predictive value of peroxisome proliferation in identifying certain nonmutagenic carcinogens","volume":"97","author":"Nemali","year":"1989","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB34","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1126\/science.1198095","article-title":"Hepatic peroxisome proliferation: induction by two novel compounds structurally unrelated to clofibrate","volume":"190","author":"Reddy","year":"1975","journal-title":"Science"},{"key":"10.1016\/S0027-5107(99)00232-8_BIB35","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s002040050250","article-title":"Tissue specific basal expression of soluble murine epoxide hydrolase and effects of clofibrate on the mRNA levels in extrahepatic tissues and liver","volume":"70","author":"Johansson","year":"1995","journal-title":"Arch. Toxicol."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB36","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0024-3205(98)00249-5","article-title":"Bezafibrate has an antioxidant effect: peroxisome proliferator-activated receptor \u03b1 is associated with Cu2+, Zn2+-superoxide dismutase in the liver","volume":"63","author":"Inoue","year":"1998","journal-title":"Life Sci."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB37","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1006\/faat.1995.1134","article-title":"Peroxisome proliferation and microsomal enzyme induction by the hypolipidemic CI-924 in rats and mice: relationship to tumorigenicity","volume":"27","author":"Hofstra","year":"1995","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB38","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/carcin\/13.6.1011","article-title":"Contrasting hepatocytic peroxisome proliferation, lipofuscin accumulation and cell turnover for the hepatocarcinogens WY-14,643 and clofibric acid","volume":"15","author":"Marsman","year":"1992","journal-title":"Carcinogenesis"},{"key":"10.1016\/S0027-5107(99)00232-8_BIB39","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1093\/carcin\/14.12.2495","article-title":"Elevated 8-hydroxydeoxyguanosine in hepatic DNA of rats following exposure to peroxisome proliferators: relationship to carcinogenesis and nuclear localization","volume":"14","author":"Cattley","year":"1993","journal-title":"Carcinogenesis"},{"key":"10.1016\/S0027-5107(99)00232-8_BIB40","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1093\/carcin\/16.8.1795","article-title":"Elevated 8-hydroxydeoxyguanosine in hepatic DNA following exposure to peroxisome proliferators: relationship to mitochondrial alterations","volume":"16","author":"Sausen","year":"1995","journal-title":"Carcinogenesis"},{"key":"10.1016\/S0027-5107(99)00232-8_BIB41","doi-asserted-by":"crossref","first-page":"24698","DOI":"10.1074\/jbc.271.40.24698","article-title":"Hepatocellular and hepatic peroxisome alterations in mice with a disrupted peroxisomal fatty acyl-coenzyme A oxidase gene","volume":"271","author":"Fan","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB42","doi-asserted-by":"crossref","first-page":"15639","DOI":"10.1074\/jbc.273.25.15639","article-title":"Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase. Implications for peroxisome proliferator-activated receptor alpha natural ligand metabolism","volume":"273","author":"Fan","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB43","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF00229469","article-title":"Omega-3 fatty acids and the peroxisome","volume":"165","author":"Masters","year":"1996","journal-title":"Mol. Cell. Biochem."},{"year":"1991","series-title":"Chemically Induced Cell Proliferation: Implications for Risk Assessment","author":"Butterworth","key":"10.1016\/S0027-5107(99)00232-8_BIB44"},{"key":"10.1016\/S0027-5107(99)00232-8_BIB45","first-page":"6739","article-title":"Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl) phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (WY-14,643) in rats","volume":"48","author":"Marsman","year":"1988","journal-title":"Cancer Res."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB46","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1749-6632.1996.tb18647.x","article-title":"Non-genotoxic hepatocarcinogenesis: suppression of apoptosis by peroxisome proliferators","volume":"804","author":"Roberts","year":"1996","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB47","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1177\/096032719401300201","article-title":"Mechanistically based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis","volume":"13","author":"Ashby","year":"1994","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB48","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1093\/carcin\/12.9.1557","article-title":"Hepatocellular DNA synthesis in rats given peroxisome proliferating agents: comparison of WY-14,463 to clofibric acid, nafenopin and LY171883","volume":"12","author":"Eacho","year":"1991","journal-title":"Carcinogenesis"},{"key":"10.1016\/S0027-5107(99)00232-8_BIB49","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1093\/carcin\/14.7.1451","article-title":"Comparison of the acute and chronic mitogenic effects of the peroxisome proliferator methylclofenapate and clofibric acid in rat liver","volume":"14","author":"Barrass","year":"1993","journal-title":"Carcinogenesis"},{"key":"10.1016\/S0027-5107(99)00232-8_BIB50","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0041-008X(92)90146-J","article-title":"Studies of early hepatocellular proliferation and peroxisomal proliferation in Sprague\u2013Dawley rats treated with tumorigenic doses of clofibrate","volume":"116","author":"Tanaka","year":"1992","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB51","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/carcin\/12.3.469","article-title":"Age-related susceptibility to the carcinogenic effect of the peroxisome proliferation WY-14,643 in rat liver","volume":"12","author":"Cattley","year":"1991","journal-title":"Carcinogenesis"},{"key":"10.1016\/S0027-5107(99)00232-8_BIB52","first-page":"666","article-title":"Increased susceptibility of aged rats to hepatocarcinogenesis by the peroxisome proliferator nafenopin and the possible involvement of altered liver foci occurring spontaneously","volume":"51","author":"Kraupp-Grasl","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB53","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/carcin\/3.10.1231","article-title":"The absence of gamma-glutamyl transpeptidase activity in putative preneoplastic lesions and in hepatocellular carcinomas induced in rats by the hypolipidemic peroxisome proliferator WY-14,643","volume":"3","author":"Rao","year":"1982","journal-title":"Carcinogenesis"},{"key":"10.1016\/S0027-5107(99)00232-8_BIB54","first-page":"4919","article-title":"Lack of expression of glutathione-S-transferase P, gamma-glutamyl transpeptidase and alpha-fetoprotein messenger RNAs in liver tumors induced by peroxisome proliferator","volume":"48","author":"Rao","year":"1988","journal-title":"Cancer Res."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB55","first-page":"3701","article-title":"Tumor promotion by the peroxisome proliferator nafenopin involving a specific subtype of altered foci in rat liver","volume":"50","author":"Grasl-Kraupp","year":"1990","journal-title":"Cancer Res."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB56","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/carcin\/14.5.1007","article-title":"Enhancement of peroxisomal enzymes, cytochrome P-452 and DNA synthesis in putative preneoplastic foci of rat liver treated with the peroxisome proliferator nafenopin","volume":"14","author":"Grasl-Kraupp","year":"1993","journal-title":"Carcinogenesis"},{"key":"10.1016\/S0027-5107(99)00232-8_BIB57","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1093\/carcin\/14.11.2435","article-title":"Peroxisomal enzyme induction uncoupled from enhanced DNA synthesis in putative preneoplastic liver foci of rats treated with a single dose of the peroxisome proliferator nafenopin","volume":"14","author":"Grasl-Kraupp","year":"1993","journal-title":"Carcinogenesis"},{"key":"10.1016\/S0027-5107(99)00232-8_BIB58","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/hep.510250420","article-title":"Inherent increase of apoptosis in liver tumors: implications for carcinogenesis and tumor regression","volume":"25","author":"Grasl-Kraupp","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/S0027-5107(99)00232-8_BIB59","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/carcin\/15.1.111","article-title":"Biological potential of basophilic hepatocellular foci and hepatic adenoma induced by peroxisome proliferator, WY-14,643","volume":"15","author":"Marsman","year":"1994","journal-title":"Carcinogenesis"},{"key":"10.1016\/S0027-5107(99)00232-8_BIB60","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/carcin\/16.1.77","article-title":"TGF\u03b1 is differentially expressed in liver foci induced by diethylnitrosamine initiation and peroxisome proliferator promotion","volume":"16","author":"Miller","year":"1995","journal-title":"Carcinogenesis"},{"key":"10.1016\/S0027-5107(99)00232-8_BIB61","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1093\/carcin\/17.6.1337","article-title":"Effects on the expression of c-met, c-myc and PPAR\u03b1 in liver and liver tumors from rats chronically exposed to the hepatocarcinogenic peroxisome proliferator WY-14,643","volume":"17","author":"Miller","year":"1996","journal-title":"Carcinogenesis"},{"key":"10.1016\/S0027-5107(99)00232-8_BIB62","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/mc.2940070206","article-title":"Lack of mutations of the p53 tumor suppressor gene in hepatocellular carcinomas induced in rats by a peroxisome proliferator","volume":"78","author":"Smith","year":"1993","journal-title":"Mol. Carcinog."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB63","unstructured":"S.A. Anderson, R.C. Cattley, J.C. Corton, Upregulation of acute-phase protein gene expression in peroxisome proliferator-induced hepatocellular adenomas in the rat, Mol. Carcinog. (in press)."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB64","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/carcin\/13.2.265","article-title":"Loss of peroxisomal enzyme in preneoplastic and neoplastic lesions induced by peroxisome proliferator in rat livers","volume":"13","author":"Yokoyama","year":"1992","journal-title":"Carcinogenesis"},{"key":"10.1016\/S0027-5107(99)00232-8_BIB65","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/carcin\/14.3.393","article-title":"Lack of peroxisomal enzyme inducibility in rat hepatic preneoplastic lesions induced by mutagenic carcinogens: contrasted expression of glutathione S-transferase P form and enoyl CoA hydratase","volume":"14","author":"Yokoyama","year":"1993","journal-title":"Carcinogenesis"},{"key":"10.1016\/S0027-5107(99)00232-8_BIB66","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1093\/carcin\/15.11.2619","article-title":"Expression of peroxisomal enoyl-CoA hydratase\/3-hydroxyacyl-CoA dehydrogenase enzyme and its mRNA in peroxisome proliferator-induced liver tumors","volume":"15","author":"Rao","year":"1994","journal-title":"Carcinogenesis"},{"key":"10.1016\/S0027-5107(99)00232-8_BIB67","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/carcin\/20.6.985","article-title":"Impairment of peroxisomal biogenesis in human colon carcinoma","volume":"20","author":"Lauer","year":"1999","journal-title":"Carcinogenesis"},{"key":"10.1016\/S0027-5107(99)00232-8_BIB68","series-title":"New Developments in Fatty Acid Oxidation","first-page":"253","article-title":"Role of peroxisomes in the degradation of prostaglandins","author":"Diczfalusy","year":"1992"},{"key":"10.1016\/S0027-5107(99)00232-8_BIB69","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0016-5085(93)90725-R","article-title":"Prostaglandin E2 and rat liver regeneration","volume":"105","author":"Tsujii","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/S0027-5107(99)00232-8_BIB70","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/jcp.1041640304","article-title":"On the mechanisms of growth-promoting effect of prostaglandins in hepatocytes: the relationship between stimulation of DNA synthesis and signaling mediated by adenyl cyclase and phosphoinositide-specific phospholipase C","volume":"164","author":"Refsnes","year":"1995","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB71","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/hep.1840140225","article-title":"Kupffer cell prostaglandin-E2 production is amplified during hepatic regeneration","volume":"14","author":"Callery","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/S0027-5107(99)00232-8_BIB72","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/S0022-2275(20)41490-7","article-title":"Effects of n\u22123 and n\u22126 polyunsaturated fatty acid-enriched diets on lipid metabolism in periportal and pericentral compartments of female rat liver lobules and the consequences for cell proliferation after partial hepatectomy","volume":"36","author":"Van Noordeen","year":"1995","journal-title":"J. Lipid Res."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB73","first-page":"687","article-title":"Eicosanoids and cancer","volume":"222","author":"Karmali","year":"1986","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB74","doi-asserted-by":"crossref","first-page":"9401","DOI":"10.1073\/pnas.87.23.9401","article-title":"Preferential binding of growth inhibitory prostaglandins by the target protein of a carcinogen","volume":"87","author":"Khan","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB75","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0090-6980(92)90086-9","article-title":"Inhibitory effect of prostaglandin delta 12-PGJ2 on cell proliferation and alpha-fetoprotein expression in HuH-7 human hepatoma cells","volume":"43","author":"Mitsuoka","year":"1992","journal-title":"Prostaglandins"},{"key":"10.1016\/S0027-5107(99)00232-8_BIB76","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1128\/MCB.15.6.3012","article-title":"Targeted disruption of the \u03b1 isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators","volume":"15","author":"Lee","year":"1995","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB77","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1124\/mol.54.3.463","article-title":"Down-regulation of cytochrome P450 2C family members and positive acute-phase response gene expression by peroxisome proliferator chemicals","volume":"54","author":"Corton","year":"1998","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB78","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1093\/jnci\/90.22.1702","article-title":"Mechanism of action of the nongenotoxic peroxisome proliferator-activator receptor alpha","volume":"90","author":"Gonzalez","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB79","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1093\/carcin\/18.11.2029","article-title":"Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator WY-14,643","volume":"18","author":"Peters","year":"1997","journal-title":"Carcinogenesis"},{"volume":"Vol. 66","year":"1996","key":"10.1016\/S0027-5107(99)00232-8_BIB80"},{"key":"10.1016\/S0027-5107(99)00232-8_BIB81","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/0278-6915(93)90225-N","article-title":"Hepatic peroxisome proliferation in rodents and its significance for humans","volume":"31","author":"Bentley","year":"1993","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB82","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/carcin\/20.3.369","article-title":"The peroxisome proliferator (PP) response element upstream of the human acyl CoA oxidase gene is inactive among a sample human population: significance for species differences in response to PPs","volume":"20","author":"Woodyatt","year":"1999","journal-title":"Carcinogenesis"},{"key":"10.1016\/S0027-5107(99)00232-8_BIB83","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00041433-199906000-00007","article-title":"Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular imflammation and atherosclerosis","volume":"10","author":"Fruchart","year":"1999","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB84","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0960-0760(94)90089-2","article-title":"Human and rat peroxisome proliferator activated receptor (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators","volume":"51","author":"Mukherjee","year":"1994","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB85","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.1021\/bi00072a015","article-title":"CDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor","volume":"23","author":"Sher","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/S0027-5107(99)00232-8_BIB86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/jme.0.0220001","article-title":"Peroxisome proliferator-activated receptor alpha: role in rodent liver cancer and species differences","volume":"22","author":"Holden","year":"1999","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB87","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1515\/bchm.1997.378.7.651","article-title":"PPAR alpha structure\u2013function relationships derived from species-specific differences in responsiveness to hypolipidemic agents","volume":"378","author":"Keller","year":"1997","journal-title":"Biol. Chem."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB88","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/0006-2952(96)00340-1","article-title":"Activation of a human peroxisome proliferator-activated receptor by the antitumor agent phenylacetate and its analogs","volume":"52","author":"Pineau","year":"1996","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB89","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0014-5793(92)80734-X","article-title":"Induction of the peroxisome proliferator activated receptor by fenofibrate in rat liver","volume":"309","author":"Gebel","year":"1992","journal-title":"FEBS Lett."},{"key":"10.1016\/S0027-5107(99)00232-8_BIB90","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1124\/mol.53.1.14","article-title":"Peroxisome proliferator activated receptor-alpha expression in human liver","volume":"53","author":"Palmer","year":"1998","journal-title":"Mol. Pharmacol."}],"container-title":["Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027510799002328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027510799002328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T13:20:46Z","timestamp":1764681646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0027510799002328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3]]},"references-count":90,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,3]]}},"alternative-id":["S0027510799002328"],"URL":"https:\/\/doi.org\/10.1016\/s0027-5107(99)00232-8","relation":{},"ISSN":["1386-1964"],"issn-type":[{"type":"print","value":"1386-1964"}],"subject":[],"published":{"date-parts":[[2000,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Central role of PPAR\u03b1 in the mechanism of action of hepatocarcinogenic peroxisome proliferators","name":"articletitle","label":"Article Title"},{"value":"Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0027-5107(99)00232-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2000 Elsevier Science B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}